ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 22:20 (711 d 22:00 ago) – Posting: # 20047
Views: 3,291

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,357 posts in 4,459 threads, 1,492 registered users;
online 11 (0 registered, 11 guests [including 5 identified bots]).
Forum time: Saturday 20:20 CET (Europe/Vienna)

The way to do research is to attack the facts
at the point of greatest astonishment.    Celia Green

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5